Daniel Mark Wechsler serves as Executive at MELINTA THERAPEUTICS, INC. /NEW/, where they oversee executive responsibilities. Since joining the company, Daniel Mark Wechsler has executed 1 insider transactions totaling $250.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 29, 2018 involved purchasing 50,000 shares valued at $250.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 29, 2018 | MLNT | $250.0K | Purchase | 50,000 | $5.00 | Discretionary |
Daniel Mark Wechsler currently holds 50,000 shares of MELINTA THERAPEUTICS, INC. /NEW/ (MLNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Mark Wechsler has been a net buyer of MLNT stock. They have purchased $250.0K and sold $0 worth of shares.
Daniel Mark Wechsler's most recent insider trade was on May 29, 2018, when they purchased 50,000 shares at $5.00 per share.
Get notified when new Form 4 filings are submitted